Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
5,652
Funds Holding Change
+440
Funds Holding Growth
+8%
Value
$1.39T
Holding in Top 10
716
Top 10 Change
-99
Top 10 Growth
-12%
Value Growth
-9%
New
677
Increased
1,991
Reduced
2,703
Closed
138
Capital Inflow
$73B
Capital Outflow
$40B
Net Capital Flow
+$33B
Capital Flow Change
+$23.9B
Calls
$19.8B
Puts
$18.5B
Net Calls
+$1.35B
Put/Call Ratio
0.93